Aller au contenu
Santé cardiovasculaireRevue des preuves4 min read

More dietary fibre: lower blood pressure in hypertension, and lower mortality in heart disease

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Dietary fibre in hypertension and cardiovascular disease management: systematic review and meta-analyses. · BMC medicine · 2022 · Article original ↗

À retenir

Pooling 12 trials in 878 adults with heart disease or hypertension, higher fibre intake lowered systolic blood pressure by 4.3 mmHg and diastolic by 3.1 mmHg in people with hypertension; in 3 cohorts of 7469 adults with heart disease, higher fibre intake was linked to lower all-cause mortality (RR 0.75). The mortality finding is observational and based on only three studies, and several other outcomes were rated low certainty.

Study design

Revue des preuves

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Eating more fibre is linked to a lower risk of developing cardiovascular disease (CVD) and lowers blood pressure, but it is not clear whether it adds benefit for people who already have CVD and take protective drugs. The authors reviewed the evidence for fibre as an add-on to treatment in people with CVD or hypertension.

Population et méthode

Systematic review and meta-analysis. Ovid MEDLINE, Embase, PubMed and CENTRAL were searched to June 2021. Eligible were prospective observational studies of fibre intake and mortality in people with existing CVD, and controlled trials of increased fibre on cardiometabolic risk factors in people with CVD or hypertension. Data were combined with random-effects models and dose-response analysis, and certainty of evidence was graded with GRADE. The review found 3 prospective studies (7469 adults with CVD) and 12 trials (878 adults with CVD or hypertension).

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Higher fibre intake was associated with lower all-cause mortality in adults with CVD (relative risk 0.75, 95% CI 0.58-0.97), with moderate certainty evidence.
  2. 2
    In adults with hypertension, increasing fibre lowered systolic blood pressure by 4.3 mmHg (95% CI 2.2 to 5.8) and diastolic by 3.1 mmHg (95% CI 1.7 to 4.4), with high certainty evidence.
  3. 3
    In adults with CVD, low certainty evidence showed reductions in total cholesterol (mean difference -0.42 mmol/L, 95% CI -0.78 to -0.05) and LDL cholesterol (-0.47 mmol/L, 95% CI -0.85 to -0.10).
  4. 4
    Fasting blood glucose also improved (mean difference 0.48 mmol/L, 95% CI -0.91 to -0.05), with moderate or low certainty. The authors report benefits irrespective of cardioprotective drug use.

Limites et incertitude

  1. 1
    The mortality result rests on only 3 observational studies, so it cannot show that eating more fibre caused fewer deaths.
  2. 2
    Only 12 trials with 878 adults in total were pooled, and much of the evidence on cholesterol and glucose was graded low or moderate certainty.
  3. 3
    The abstract lists a second LDL cholesterol estimate (0.29 mmol/L, 95% CI 0.17 to 0.40) whose sign differs from the first, and does not explain which population it covers, so the LDL result should be read cautiously.
  4. 4
    The authors themselves say further trials and cohort analyses are needed to increase confidence.

Mise en perspective

If you have high blood pressure or heart disease, getting more fibre from food is a reasonable addition to, not a replacement for, the treatment your clinician prescribes. The blood pressure drop was modest and the mortality link is not proof. Discuss any large change in diet with your clinician.

Vos données

If you take blood pressure readings at home, use the same cuff, time of day and posture, and compare weekly averages before and after raising your fibre. A food log can show your average daily fibre intake, and changes are best judged over several weeks, not single readings.

Comprendre ce type de preuve

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Higher dietary fibre intakes are associated with a reduced risk of developing cardiovascular disease (CVD), and increasing intake has been shown to reduce blood pressure and other cardiometabolic risk factors. The extent to which dietary fibre can further reduce risk for those with CVD and treated with cardioprotective drugs has not been clearly established. We have examined the evidence for dietary fibre as adjunct therapy in those with CVD or hypertension.

Methods

Ovid MEDLINE, Embase, PubMed, and CENTRAL were searched to June 2021. Prospective observational studies reporting on fibre intakes and mortality in those with pre-existing CVD and controlled trials of increasing fibre intakes on cardiometabolic risk factors in those with CVD or hypertension were eligible. Outcomes were mortality (studies) and cardiometabolic risk factors (trials). Data synthesis was with random effects and dose response. Certainty of evidence was assessed using GRADE.

Results

Three prospective studies including 7469 adults with CVD, and 12 trials of 878 adults with CVD or hypertension were identified. Moderate certainty evidence indicates reduced all-cause mortality (relative risk, RR0.75 (95% confidence interval, CI 0.58-0.97)) when comparing higher with lower fibre intakes. Low certainty evidence from trials of adults with cardiovascular disease indicates increasing fibre intakes reduced total (mean difference, MD - 0.42 mmol/L (95%CI - 0.78 to - 0.05) and low-density lipoprotein (LDL) cholesterol (MD - 0.47mmol/L (95%CI - 0.85 to - 0.10)). High certainty evidence from trials of adults with hypertension indicates increasing fibre intakes reduces systolic (MD 4.3 mmHg (95% CI 2.2 to 5.8)) and diastolic blood pressure (MD 3.1 mmHg (95% CI 1.7 to 4.4)). Moderate and low certainty evidence indicated improvements in fasting blood glucose (MD 0.48 mmol/L (- 0.91 to - 0.05)) and LDL cholesterol (MD 0.29 mmol/L (95% CI 0.17 to 0.40)). Benefits were observed irrespective of cardioprotective drug use.

Conclusions

These findings emphasise the likely benefits of promoting greater dietary fibre intakes for patients with CVD and hypertension. Further trials and cohort analyses in this area would increase confidence in these results.

Sources et attribution

Dietary fibre in hypertension and cardiovascular disease management: systematic review and meta-analyses.

Reynolds AN, Akerman A, Kumar S, Diep Pham HT, Coffey S, Mann J.

BMC medicine · 2022-04-22

DOI: 10.1186/s12916-022-02328-x ↗PubMed · 35449060 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse observationnelle

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Essai randomisé

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
·Validation : étude/revue

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
Santé cardiovasculaire →